12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Azanta, Medigene sales and marketing update

MediGene granted Azanta exclusive rights to market Veregen sinecatechins in Denmark, Sweden, Norway, Finland and Iceland to treat genital and perianal warts....

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >